ORLANDO — While there will always be points of friction in the market, unmet needs in ophthalmology will ultimately yield innovation, according to a speaker at Eyecelerator@AAO.In an ophthalmic market overview, Kristen Harmon Ingenito, MBA, CEO of Mark…
Insights from AAO 2025, including anticipated presentations, key takeaways, and how emerging research on non-AMD retinal disorders may affect patient care. Medscape
Dr Sunir Garg looks ahead to presentations on new developments in retinal eye disease treatments, medication risks, and updated screening guidelines. Medscape
Editor’s note: This is a developing news story. Please check back soon for updates.EssilorLuxottica added to its medical technology portfolio with the acquisition of Ikerian AG, a Swiss health tech company doing business under the name RetinAI, accordi…
Thousands of patients have presented to emergency departments with ocular injuries sustained while playing the increasingly popular sport, researchers estimate. Medscape Medical News
Iantrek launched AlloFlo Uveo, a bio-interventional surgical treatment that targets the uveoscleral pathway in patients with glaucoma, according to a press release.“Over the past 15 years, glaucoma surgeons have seen dozens of technologies become avail…